Shandong Wit Dyne Health Co.,Ltd. (SHE:000915)

Market Cap	7.74B
Revenue (ttm)	2.18B
Net Income (ttm)	529.31M
Shares Out	234.33M
EPS (ttm)	2.26
PE Ratio	14.62
Forward PE	14.06
Dividend	2.50 (7.48%)
Ex-Dividend Date	Jun 11, 2025

Volume	6,003,123
Average Volume	6,544,496
Open	32.69
Previous Close	33.42
Day's Range	32.69 - 33.50
52-Week Range	23.61 - 35.74
Beta	-0.02
RSI	57.07
Earnings Date	Jul 7, 2025

About Shandong Wit Dyne Health

Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, licorice zinc granules, compound calcium carbonate, vitamin AD drops, epalrestat tablets, valsartan hydrochlorothiazide gel, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company also provides dextran iron granules, oral rehydration salt powder, montmorillonite powder, zithromycin granules, rifaximin dry suspension, and dithiothreitol succinate capsules. In addition, it offers infor...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1993
• Employees: 1,759
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000915

Financial Performance

In 2024, Shandong Wit Dyne Health's revenue was 2.13 billion, a decrease of -14.08% compared to the previous year's 2.48 billion. Earnings were 515.59 million, a decrease of -11.90%.